SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-023442
Filing Date
2023-07-05
Accepted
2023-07-05 16:17:36
Documents
15
Period of Report
2023-07-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 74484
2 ex10-1.htm EX-10.1 140276
3 ex99-1.htm EX-99.1 28833
4 ex99-1_001.jpg GRAPHIC 11318
  Complete submission text file 0001493152-23-023442.txt   473938

Data Files

Seq Description Document Type Size
5 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vbiv-20230705.xsd EX-101.SCH 3024
6 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vbiv-20230705_lab.xml EX-101.LAB 34240
7 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vbiv-20230705_pre.xml EX-101.PRE 22365
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3242
Mailing Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142
Business Address 160 SECOND STREET CAMBRIDGE CAMBRIDGE MA 02142 617-830-3031
VBI Vaccines Inc/BC (Filer) CIK: 0000764195 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37769 | Film No.: 231069205
SIC: 2834 Pharmaceutical Preparations